FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
EntreMed Reports Third Quarter 2013 Financial Results
November 14, 2013
Data Presented For ENMD-2076 In Preclinical Models Of Triple-Negative Breast Cancer
October 21, 2013
EntreMed Reports Second Quarter 2013 Financial Results
August 14, 2013
EntreMed Initiates Crossover Bioavailability And Food Effect Study Of ENMD-2076 Dosage Form To Be Used For Pivotal/Registration Clinical Trials
July 29, 2013
EntreMed Files New Drug Global Clinical Trial Application For ENMD-2076 With China CFDA To Expand Clinical Trial For Advanced/Metastatic Sarcoma
June 27, 2013
EntreMed, Inc. New (ENMD) Reports Q4 Loss of $0.05/Share
March 21, 2014
EntreMed Files New Drug Global Clinical Trial Application For ENMD-2076 With China CFDA
January 13, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here